Brief: Verrica Pharmaceuticals Reports Strong Demand-Led Growth In Ycanth® In Q1 2025
07/04/2025 13:49
April 7 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O: VERRICA PHARMACEUTICALS REPORTS STRONG DEMAND-LED GROWTH IN YCANTH® DISPENSED APPLICATOR UNITS IN FIRST QUARTER 2025 Source text: ID:nGNX3Dnw0M Further company coverage: VRCA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Verrica Pharmaceuticals
See all newsVerrica Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Verrica Pharma reports wider-than-expected Q2 adj loss per share
Verrica Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Verrica Pharmaceuticals Q1 revenue rises on YCANTH demand
Brief: Verrica Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Data